Page last updated: 2024-10-25

cimetidine and Telangiectasia, Hereditary Hemorrhagic

cimetidine has been researched along with Telangiectasia, Hereditary Hemorrhagic in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Telangiectasia, Hereditary Hemorrhagic: An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kueh, YK1
LaBrooy, S1

Other Studies

1 other study available for cimetidine and Telangiectasia, Hereditary Hemorrhagic

ArticleYear
Hereditary haemorrhagic telangiectasia: the use of H2 receptor antagonist in symptomatic gastric telangiectasia.
    Annals of the Academy of Medicine, Singapore, 1985, Volume: 14, Issue:4

    Topics: Aged; Cimetidine; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Pedigree; Rec

1985